Vestal Point Capital reported a 3% stake in Dianthus Therapeutics DNTH · 1,180,000 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 3%
Last report: 9.95% · filed 25/08/14
Shares held: 1,180,000 sh
Class: Common Stock, par value $0.001 per share
Stock: Dianthus Therapeutics DNTH
Holder: Vestal Point Capital
Event date: 25/09/30
Filed: 25/11/14

3% stake · below 5%

Stake: 3%
Last report: 9.95%
Since last report: −7.0pp

Dianthus Therapeutics trades, last 26 weeks

What else happened in Dianthus Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Vestal Point Capital's other 5% stake reports

Vestal Point Capital
5% stakeMonte Rosa Therapeutics
5% stake
Monte Rosa Therapeutics
GLUE
5.4% stake
4,600,000 sh
5.4% stake
Filed 08/14
Vestal Point Capital
5% stakeMyriad Genetics
5% stake
Myriad Genetics
MYGN
6.1% stake
5,735,000 sh
6.1% stake
Filed 08/14
Vestal Point Capital
5% stakeSolid Biosciences
5% stake
Solid Biosciences
SLDB
4.8% stake
4,833,796 sh
4.8% stake
Filed 08/14
Vestal Point Capital
5% stakeImmunocore Holdings
5% stake
Immunocore Holdings
IMCR
3.5% stake
1,800,000 sh
3.5% stake
Filed 08/14
Vestal Point Capital
5% stakeNurix Therapeutics
5% stake
Nurix Therapeutics
NRIX
7.8% stake
8,050,000 sh
7.8% stake
Filed 08/14